nodes	percent_of_prediction	percent_of_DWPC	metapath
Homatropine Methylbromide—CHRM3—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00824	0.00824	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00812	0.00812	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00798	0.00798	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00777	0.00777	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00764	0.00764	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00762	0.00762	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00739	0.00739	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00737	0.00737	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.0073	0.0073	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00724	0.00724	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00696	0.00696	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00694	0.00694	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00693	0.00693	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00687	0.00687	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00683	0.00683	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00634	0.00634	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00632	0.00632	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00626	0.00626	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00618	0.00618	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00603	0.00603	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00592	0.00592	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00583	0.00583	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00567	0.00567	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00558	0.00558	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—TSHR—adrenal gland cancer	0.00551	0.00551	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00547	0.00547	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00546	0.00546	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0054	0.0054	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00538	0.00538	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00536	0.00536	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00531	0.00531	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0053	0.0053	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00529	0.00529	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—TSHR—adrenal gland cancer	0.00528	0.00528	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00514	0.00514	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00512	0.00512	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00507	0.00507	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00507	0.00507	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00507	0.00507	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00488	0.00488	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00486	0.00486	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00485	0.00485	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00482	0.00482	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00417	0.00417	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00415	0.00415	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00411	0.00411	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00393	0.00393	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00392	0.00392	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00388	0.00388	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00372	0.00372	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.0037	0.0037	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00367	0.00367	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00357	0.00357	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00356	0.00356	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00356	0.00356	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00352	0.00352	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00352	0.00352	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00349	0.00349	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00342	0.00342	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00341	0.00341	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00337	0.00337	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00335	0.00335	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—GNAS—adrenal gland cancer	0.0032	0.0032	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00317	0.00317	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—GNRHR—adrenal gland cancer	0.00313	0.00313	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00311	0.00311	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00307	0.00307	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00304	0.00304	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.003	0.003	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00298	0.00298	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00291	0.00291	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.0029	0.0029	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00283	0.00283	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—TSHR—adrenal gland cancer	0.00283	0.00283	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00278	0.00278	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00278	0.00278	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00275	0.00275	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00273	0.00273	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00271	0.00271	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00271	0.00271	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00262	0.00262	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00237	0.00237	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00236	0.00236	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00235	0.00235	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00235	0.00235	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00233	0.00233	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00216	0.00216	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—POMC—adrenal gland cancer	0.00216	0.00216	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00215	0.00215	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00214	0.00214	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00213	0.00213	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00213	0.00213	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.0021	0.0021	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0021	0.0021	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00209	0.00209	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00208	0.00208	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00195	0.00195	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00195	0.00195	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00191	0.00191	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00191	0.00191	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00189	0.00189	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00188	0.00188	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00187	0.00187	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00184	0.00184	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00184	0.00184	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00181	0.00181	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00179	0.00179	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00177	0.00177	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00177	0.00177	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00173	0.00173	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—SPRY2—adrenal gland cancer	0.00171	0.00171	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—TSHR—adrenal gland cancer	0.00167	0.00167	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—GNAS—adrenal gland cancer	0.00164	0.00164	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00164	0.00164	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00158	0.00158	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—MEN1—adrenal gland cancer	0.00157	0.00157	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00146	0.00146	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00146	0.00146	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00144	0.00144	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00136	0.00136	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00135	0.00135	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00132	0.00132	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00127	0.00127	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	0.00098	0.00098	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	0.000974	0.000974	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	0.000972	0.000972	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000964	0.000964	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000948	0.000948	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	0.000939	0.000939	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	0.00093	0.00093	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	0.000907	0.000907	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000822	0.000822	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.00082	0.00082	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	0.000816	0.000816	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000812	0.000812	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000808	0.000808	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000806	0.000806	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000798	0.000798	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	0.000781	0.000781	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000781	0.000781	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000766	0.000766	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000747	0.000747	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000744	0.000744	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000737	0.000737	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	0.00071	0.00071	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000686	0.000686	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000683	0.000683	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.00068	0.00068	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000677	0.000677	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000661	0.000661	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000659	0.000659	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000655	0.000655	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	0.000654	0.000654	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000653	0.000653	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000652	0.000652	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000647	0.000647	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	0.000646	0.000646	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000639	0.000639	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000637	0.000637	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000631	0.000631	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	0.000626	0.000626	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000626	0.000626	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.000619	0.000619	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.0006	0.0006	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.00055	0.00055	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000548	0.000548	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000543	0.000543	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000526	0.000526	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000478	0.000478	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000477	0.000477	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000472	0.000472	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000467	0.000467	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000447	0.000447	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000441	0.000441	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.00044	0.00044	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000436	0.000436	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000435	0.000435	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000434	0.000434	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.00043	0.00043	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000422	0.000422	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000421	0.000421	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000419	0.000419	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000417	0.000417	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	0.00037	0.00037	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	0.000354	0.000354	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000315	0.000315	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000314	0.000314	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000311	0.000311	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	0.000311	0.000311	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	0.000297	0.000297	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000249	0.000249	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000249	0.000249	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000246	0.000246	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000209	0.000209	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000209	0.000209	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000207	0.000207	CbGpPWpGaD
